Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells

Cancer Research

Volumn 66, Issue 23, 2006, Pages 11131-11139

  Enomoto, Tsuyoshi ^a   Oda, Tatsuya ^a   Aoyagi, Yasuyuki ^a   Sugiura, Shinji ^b   Nakajima, Mitsutoshi ^c   Satake, Mitsuo ^d   Noguchi, Masayuki ^a   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; IRINOTECAN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL ENCAPSULATION; CELL PROLIFERATION; CELL SPREADING; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; LIVER METASTASIS; MALE; MICROENCAPSULATION; NONHUMAN; PANCREAS CANCER; PORTAL VEIN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; HUMANS; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MICROSPHERES; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PORTAL VEIN; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 33845806425     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0339     Document Type: Article

References (50)

1. Mao C, Domenico DR, Kim K, Hanson DJ, Howard JM. Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies. Arch Surg 1995;130:125-34.
2. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-10.
3. Kozlowski JM, Fidler IJ, Campbell D, et al. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984;44:3522-9.
4. Vezeridis MP, Meitner PA, Tibbetts LM, et al. Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma. J Surg Res 1990;48:51-5.
5. Morikawa K, Walker SM, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988;48:1943-8.
6. Yasoshima T, Denno R, Kawaguchi S, et al. Establishment and characterization of human gastric carcinoma lines with high metastatic potential in the liver: changes in integrin expression associated with the ability to metastasize in the liver of nude mice. Jpn J Cancer Res 1996;87:153-60.
7. Takamori H, Hiraoka T, Yamamoto T. Expression of tumor-associated carbohydrate antigens correlates with hepatic metastasis of pancreatic cancer: clinical and experimental studies. Hepatogastroenterology 1996;43:748-55.
8. Ohta T, Futagami F, Arakawa H, et al. [Inhibitory effect of FOY-305 on liver metastasis of the pancreatic cancer]. Can To Kagaku Ryoho 1996;23:1669-72.
9. Tibbetts LM, Doremus CM, Tzanakakis GN, Vezeridis MP. Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer 1993;71:315-21.
10. Takiguchi S, Kumazawa E, Shimazoe T, Tohgo A, Kono A. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice. Jpn J Cancer Res 1997;88:760-9.
11. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:689-92.
12. Kisker O, Onizuka S, Banyard J, et al. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Cancer Res 2001;61:7298-304.
13. Tan MH, Holyoke ED, Goldrosen MH. Murine colon adenocarcinoma: syngeneic orthotopic transplantation and subsequent hepatic metastases. J Natl Cancer Inst 1977;59:1537-44.
14. Marincola F, Taylor-Edwards C, Drucker B, Holder WD, Jr. Orthotopic and heterotopic xenotransplantation of human pancreatic cancer in nude mice. Curr Surg 1987;44:294-7.
15. Fu X, Guadagni F, Hoffman RM. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci U S A 1992;89:5645-9.
16. Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM. A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 1993;53:3070-2.
17. Aubert M, Panicot L, Crotte C, et al. Restoration of α(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. Cancer Res 2000;60:1449-56.
18. Kuo TH, Kubota T, Watanabe M, et al. Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci U S A 1995;92:12085-9.
19. Pajet S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
20. Ewing J. Neoplastic disease. A treatise on tumors. 3rd ed. Philadelphia: Saunders; 1928.
21. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-10.
22. Iwamura T, Katsuki T, Ide K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res 1987;78:54-62.
23. Van Raamsdonk JM, Chang PL. Osmotic pressure test: a simple, quantitative method to assess the mechanical stability of alginate microcapsules. J Biomed Mater Res 2001;54:264-71.
24. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
25. Ueda T, Oda T, Kinoshita T, et al. Neovascularization in pancreatic ductal adenocarcinoma: microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas. Oncol Rep 2002;9:239-45.
26. Schultz HM, Merriman RL, Toth JE, et al. Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts. Oncol Res 1993;5:223-8.
27. Kusama T, Mukai M, Iwasaki T, et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology 2002;122:308-17.
28. Nakahashi C, Oda T, Kinoshita T, et al. The impact of liver metastasis on mortality in patients initially diagnosed with locally advanced or resectable pancreatic cancer. Int J Gastrointest Cancer 2003;33:155-64.
29. Honn KV, Tang DG. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev 1992;11:353-75.
30. Thorlacius H, Prieto J, Raud J, et al. Tumor cell arrest in the microcirculation: lack of evidence for a leukocyte-like rolling adhesive interaction with vascular endothelium in vivo. Clin Immunol Immunopathol 1997;83:68-76.
31. Mizuno N, Kato Y, Shirota K, et al. Mechanism of initial distribution of blood-borne colon carcinoma cells in the liver. J Hepatol 1998;28:878-85.
32. Roberts S, Watne A, McGrath R, McGrew E, Cole WH. Technique and results of isolation of cancer cells from the circulating blood. AMA Arch Surg 1958;76:334-46.
33. Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978;38:2651-60.
34. Liotta LA, Saidel MG, Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976;36:889-94.
35. Topal B, Roskams T, Fevery J, Penninckx F. Aggregated colon cancer cells have a higher metastatic efficiency in the liver compared with nonaggregated cells: an experimental study. J Surg Res 2003;112:31-7.
36. van der Elst J, De Greve J, Geerts F, et al. Quantitative study of liver metastases from colon cancer in rats after treatment with cyclosporine A. J Natl Cancer Inst 1986;77:227-32.
37. Panis Y, Ribeiro J, Chretien Y, Nordlinger B. Dormant liver metastases: an experimental study. Br J Surg 1992;79:221-3.
38. Panis Y, Nordlinger B, Delelo R, et al. Experimental colorectal liver metastases. Influence of sex, immunological status and liver regeneration. J Hepatol 1990;11:53-7.
39. Weiss L. The hemodynamic destruction of circulating cancer cells. Biorheology 1987;24:105-15.
40. Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970;45:773-82.
41. Barbera-Guillem E, Smith I, Weiss L. Cancer-cell traffic in the liver. II. Arrest, transit and death of B16F10 and M5076 cells in the sinusoids. Int J Cancer 1993;53:298-301.
42. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998;153:865-73.
43. Kimura N, Muraoka R, Horiuchi T, et al. Intermittent hepatic pedicle clamping reduces liver and lung injury. J Surg Res 1998;78:11-7.
44. Yoshida M, Horiuchi T, Uchinami M, et al. Intermittent hepatic ischemia-reperfusion minimizes liver metastasis in rats. J Surg Res 2003;111:255-60.
45. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001;13:777-84.
46. Doi K, Horiuchi T, Uchinami M, et al. Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res 2002;105:243-7.
47. van der Bilt JD, Kranenburg O, Nijkamp MW, et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 2005;42:165-75.
48. Ku Y, Kusunoki N, Shiotani M et al. Stimulation of haematogenous liver metastases by ischaemia-reperfusion in rats. Eur J Surg 1999;165:801-7.
49. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-65.
50. Yasui N, Sakamoto M, Ochiai A, et al. Tumor growth and metastasis of human colorectal cancer cell lines in SCID mice resemble clinical metastatic behaviors. Invasion Metastasis 1997;17:259-69.